BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tovo CV, Fernandes SA, Buss C, de Mattos AA. Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review. World J Hepatol 2017; 9(6): 326-332 [PMID: 28293382 DOI: 10.4254/wjh.v9.i6.326]
URL: https://www.wjgnet.com/1007-9327/full/v9/i6/326.htm
Number Citing Articles
1
Vittoria Zambon Azevedo, Cristina Alina Silaghi, Thomas Maurel, Horatiu Silaghi, Vlad Ratziu, Raluca Pais. Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver DiseaseFrontiers in Nutrition 2022; 8 doi: 10.3389/fnut.2021.774030
2
Maurizio Marra, Rosa Sammarco, Antonino De Lorenzo, Ferdinando Iellamo, Mario Siervo, Angelo Pietrobelli, Lorenzo Maria Donini, Lidia Santarpia, Mauro Cataldi, Fabrizio Pasanisi, Franco Contaldo. Assessment of Body Composition in Health and Disease Using Bioelectrical Impedance Analysis (BIA) and Dual Energy X-Ray Absorptiometry (DXA): A Critical OverviewContrast Media & Molecular Imaging 2019; 2019: 1 doi: 10.1155/2019/3548284
3
Gang Li, Rafael S. Rios, Xin-Xin Wang, Yue Yu, Kenneth I. Zheng, Ou-Yang Huang, Liang-Jie Tang, Hong-Lei Ma, Yi Jin, Giovanni Targher, Christopher D. Byrne, Xiao-Yan Pan, Ming-Hua Zheng. Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver diseaseBritish Journal of Nutrition 2022; 127(11): 1613 doi: 10.1017/S0007114521002415
4
Stephan C. Bischoff, Johann Ockenga, Ahad Eshraghian, Rocco Barazzoni, Luca Busetto, Marjo Campmans-Kuijpers, Vincenzo Cardinale, Irit Chermesh, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon-Sanz, Juan M. Mendive, Michael W. Müller, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda. Practical guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guidelineClinical Nutrition 2023; 42(6): 987 doi: 10.1016/j.clnu.2023.03.021
5
Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, Marjo Campmans-Kuijpers, Vincenzo Cardinale, Irit Chermesh, Ahad Eshraghian, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon-Sanz, Juan M. Mendive, Michael W. Müller, Johann Ockenga, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda. European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guidelineClinical Nutrition 2022; 41(10): 2364 doi: 10.1016/j.clnu.2022.07.003
6
Yu Zhai, Qian Xiao. The Common Mechanisms of Sarcopenia and NAFLDBioMed Research International 2017; 2017: 1 doi: 10.1155/2017/6297651
7
G Henin, N Lanthier, G Dahlqvist. Pathophysiological changes of the liver-muscle axis in end-stage liver disease: what is the right target?Acta Gastro Enterologica Belgica 2022; 85(4): 611 doi: 10.51821/85.4.10899
8
Beom-Jun Kim, Seong Hee Ahn, Seung Hun Lee, Seongbin Hong, Mark W. Hamrick, Carlos M. Isales, Jung-Min Koh. Lower hand grip strength in older adults with non-alcoholic fatty liver disease: a nationwide population-based studyAging 2019; 11(13): 4547 doi: 10.18632/aging.102068
9
Alessio Molfino, Sheeva Johnson, Valentina Medici. The Challenges of Nutritional Assessment in CirrhosisCurrent Nutrition Reports 2017; 6(3): 274 doi: 10.1007/s13668-017-0216-8
10
Eun Choe, Hae Kang, Boram Park, Jong Yang, Joo Kim. The Association between Nonalcoholic Fatty Liver Disease and CT-Measured Skeletal Muscle MassJournal of Clinical Medicine 2018; 7(10): 310 doi: 10.3390/jcm7100310
11
Roger F. Butterworth. L-Ornithine L-Aspartate for the Treatment of Sarcopenia in Chronic Liver Disease: The Taming of a Vicious CycleCanadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/8182195
12
Yun Kyung Cho, Han Na Jung, Eun Hee Kim, Min Jung Lee, Joong‐Yeol Park, Woo Je Lee, Hong‐Kyu Kim, Chang Hee Jung. Association between sarcopenic obesity and poor muscle quality based on muscle quality map and abdominal computed tomographyObesity 2023; 31(6): 1547 doi: 10.1002/oby.23733
13
Luigi Schiavo, Luca Busetto, Manuela Cesaretti, Shira Zelber-Sagi, Liat Deutsch, Antonio Iannelli. Nutritional issues in patients with obesity and cirrhosisWorld Journal of Gastroenterology 2018; 24(30): 3330-3346 doi: 10.3748/wjg.v24.i30.3330
14
Joana RIGOR, Raquel VASCONCELOS, Rogério LOPES, Teresa MOREIRA, Pedro BARATA, Daniela MARTINS-MENDES. Associations between muscle mass, strength, and performance and non-alcoholic fatty liver diseaseMinerva Gastroenterology 2023; 69(3) doi: 10.23736/S2724-5985.22.03097-2
15
Ji Yeon Ryu, Hyung Muk Choi, Hyung-In Yang, Kyoung Soo Kim. Dysregulated Autophagy Mediates Sarcopenic Obesity and Its Complications via AMPK and PGC1α Signaling Pathways: Potential Involvement of Gut Dysbiosis as a Pathological LinkInternational Journal of Molecular Sciences 2020; 21(18): 6887 doi: 10.3390/ijms21186887
16
Joise Teixeira, Cláudio Augusto Marroni, Paula Rosales Zubiaurre, Ana Henz, Lais Faina, Lilian Kethelyn Pinheiro, Claudio Cora Mottin, Sabrina Alves Fernandes. Phase angle and non-alcoholic fatty liver disease before and after bariatric surgeryWorld Journal of Hepatology 2020; 12(11): 1004-1019 doi: 10.4254/wjh.v12.i11.1004
17
B.S. van der Meij, Vera C. Mazurak. Fish oil supplementation and maintaining muscle mass in chronic disease: state of the evidenceCurrent Opinion in Clinical Nutrition & Metabolic Care 2020; 23(3): 164 doi: 10.1097/MCO.0000000000000648
18
So-hyeon Hong, Kyung Mook Choi. Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic ConsequencesInternational Journal of Molecular Sciences 2020; 21(2): 494 doi: 10.3390/ijms21020494
19
Diana R. Mager, Krista MacDonald, Reena L. Duke, Hayford M. Avedzi, Edward C. Deehan, Jason Yap, Kerry Siminoski, Andrea M. Haqq. Comparison of Body Composition, Muscle Strength and Cardiometabolic Profile in Children with Prader-Willi Syndrome and Non-Alcoholic Fatty Liver Disease: A Pilot StudyInternational Journal of Molecular Sciences 2022; 23(23): 15115 doi: 10.3390/ijms232315115
20
Annalisa Cespiati, Marica Meroni, Rosa Lombardi, Giovanna Oberti, Paola Dongiovanni, Anna Ludovica Fracanzani. Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic StrategiesBiomedicines 2022; 10(1): 182 doi: 10.3390/biomedicines10010182
21
Muhei Tanaka, Hiroshi Okada, Yoshitaka Hashimoto, Muneaki Kumagai, Hiromi Nishimura, Yohei Oda, Michiaki Fukui. Relationship between nonalcoholic fatty liver disease and muscle quality as well as quantity evaluated by computed tomographyLiver International 2020; 40(1): 120 doi: 10.1111/liv.14253
22
Saad Emhmed Ali, Mindie H. Nguyen. Sarcopenic Obesity in Non-Alcoholic Fatty Liver Disease—The Union of Two CulpritsLife 2021; 11(2): 119 doi: 10.3390/life11020119
23
Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, Marjo Campmans‐Kuijpers, Vincenzo Cardinale, Irit Chermesh, Ahad Eshraghian, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon‐Sanz, Juan M. Mendive, Michael W. Müller, Johann Ockenga, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda. European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guidelineUnited European Gastroenterology Journal 2022; 10(7): 663 doi: 10.1002/ueg2.12280
24
Amedeo Lonardo, Alessandro Mantovani, Giovanni Targher, Gyorgy Baffy. Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research ImplicationsInternational Journal of Molecular Sciences 2022; 23(21): 13320 doi: 10.3390/ijms232113320
25
Mathias Plauth. Comprehensive Guide to Hepatitis Advances2023; : 87 doi: 10.1016/B978-0-323-98368-6.00004-5
26
Andressa OLIVEIRA, Sabrina Alves FERNANDES, Randhall Bruce CARTERI, Cristiane Valle TOVO. EVALUATION OF REST ENERGY EXPENDITURE IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASEArquivos de Gastroenterologia 2021; 58(2): 157 doi: 10.1590/s0004-2803.202100000-27
27
Tannaz Eslamparast, Aldo J. Montano‐Loza, Maitreyi Raman, Puneeta Tandon. Sarcopenic obesity in cirrhosis—The confluence of 2 prognostic titansLiver International 2018; 38(10): 1706 doi: 10.1111/liv.13876
28
Mark L. Dreher. Dietary Patterns and Whole Plant Foods in Aging and Disease2018; : 291 doi: 10.1007/978-3-319-59180-3_10
29
Selena Z. Kuo, Myra Ahmad, Michael A. Dunn, Aldo J. Montano-Loza, Elizabeth J. Carey, Shezhang Lin, Akshata Moghe, Hui-Wei Chen, Maryam Ebadi, Jennifer C. Lai. Sarcopenia Predicts Post-transplant Mortality in Acutely Ill Men Undergoing Urgent Evaluation and Liver TransplantationTransplantation 2019; 103(11): 2312 doi: 10.1097/TP.0000000000002741
30
Manuela Merli, Barbara Lattanzi, Francesca Aprile. Sarcopenic obesity in fatty liverCurrent Opinion in Clinical Nutrition & Metabolic Care 2019; 22(3): 185 doi: 10.1097/MCO.0000000000000558
31
Hye Jun Lee, Duk Chul Lee, Choon Ok Kim. Association Between 10-Year Fracture Probability and Nonalcoholic Fatty Liver Disease With or Without Sarcopenia in Korean Men: A Nationwide Population-Based Cross-Sectional StudyFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.599339